Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°
NACompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
August 31, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
December 31, 2013
Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT
VSL#3 active probiotic
OTHER
VSL#3 placebo
Trial Locations (1)
Unknown
Bambino Gesù Children Hospital, Rome
All Listed Sponsors
lead
Bambino Gesù Hospital and Research Institute
OTHER
NCT01650025 - Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90° | Biotech Hunter | Biotech Hunter